期刊
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
卷 25, 期 5, 页码 649-664出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.berh.2011.10.014
关键词
Haemochromatosis; Iron; HFE gene; Hepcidin; Osteoporosis; Chondrocalcinosis; Osteoarthritis; CPPD; Osteoporosis; Fracture
类别
资金
- European Grant Euro-Iron [LSH-CT-2006-037296]
Genetic haemochromatosis is a hereditary disease characterised by tissue iron overload. In Caucasians it is most often due to homozygous C282Y HFE gene mutation, but other genes may be involved. Without treatment by venesections, patients can develop life-threatening visceral damage such as liver cirrhosis and carcinoma, diabetes or heart failure. This treatment has been remarkably successful in preventing these complications, but patients survive with other symptoms of the disease susceptible to impair, sometimes seriously, their quality of life. This is the case of arthropathy and osteoporosis complicating haemochromatosis. In this chapter, focus has been placed on the rheumatological complications of genetic haemochromatosis. (C) 2011 Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据